Informações:
Falhas:
ID
34602
Descrição
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION); ODM derived from: https://clinicaltrials.gov/show/NCT01541956
Link
https://clinicaltrials.gov/show/NCT01541956
Palavras-chave
Versões (1)
- 19/01/2019 19/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
19 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes NCT01541956
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
chinese t2d patients who are inadequate controlled (6.5 %< hba1c ≤9%) by metformin (≥750mg/d but ≤1000mg/d, ≥12 weeks),
boolean
ID.2
Item
type 1 diabetes and secondary diabetes
boolean
ID.3
Item
acute metabolic diabetic complications within the past 3 months.
boolean
ID.4
Item
acute infections which may influence glucose level.
boolean
ID.5
Item
evidence of significant chronic diabetic complications,
boolean
ID.6
Item
clinically significant renal impairment and hepatic impairment patients, including history of cirrhosis or chronic hepatitis,
boolean
ID.7
Item
fpg > 270 mg/dl (15 mmol/l)
boolean
ID.8
Item
any of the following disease within the past 6 months: myocardial infarction (mi); coronary artery bypass surgery or percutaneous coronary intervention; unstable angina or stroke; congestive heart failure (chf)
boolean
ID.9
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean